How autophagy affects metabolism and insulin sensitivity
Autophagy-facilitated secretion in metabolic maintenance
This study is looking at how a process in our cells called autophagy can help manage metabolism and insulin sensitivity, especially in fat tissue, which is important for keeping our bodies healthy, and it could lead to new treatments for people with type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10896198 on NIH RePORTER |
What this research studies
This research investigates a new mechanism by which autophagy, a cellular process typically associated with degradation, can regulate metabolism without breaking down cellular components. The study focuses on how this process influences insulin sensitivity, particularly in adipose tissue, which is crucial for maintaining metabolic health. By examining the role of adiponectin, a hormone linked to type 2 diabetes, the research aims to uncover how autophagy affects its secretion and overall metabolic function. Patients may benefit from insights that could lead to new treatments for metabolic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with insulin resistance or type 2 diabetes, particularly those with low levels of adiponectin.
Not a fit: Patients who do not have metabolic dysfunction or insulin sensitivity issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for improving insulin sensitivity and treating conditions like type 2 diabetes.
How similar studies have performed: While the role of autophagy in metabolism is being explored, this specific non-degradative mechanism is relatively novel and has not been extensively tested in prior research.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: He, Congcong — Northwestern University at Chicago
- Study coordinator: He, Congcong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.